Inventor
PASCAL JEAN-CLAUDE
FR33 patents
⚠️ This page may combine multiple inventors who share the name “PASCAL JEAN-CLAUDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALDERMA RES & DEV
10 patentsUS8633196B2Jan 21, 2014
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
GALDERMA RES & DEV4 citations81
US9630949B2Apr 25, 2017
Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
GALDERMA RES & DEV2 citations70
US7659421B2Feb 9, 2010
Phenylboronic acid compounds and intermediates and processes for the preparation thereof
GALDERMA RES & DEV3 citations63
US8980897B2Mar 17, 2015
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
GALDERMA RES & DEV3 citations60
US8372879B2Feb 12, 2013
4-(heterocycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
GALDERMA RES & DEV1 citations52
US7498461B2Mar 3, 2009
Method for the preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GALDERMA RES & DEV0 citations52
US9365529B2Jun 14, 2016
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
GALDERMA RES & DEV0 citations49
US7879907B2Feb 1, 2011
3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof
GALDERMA RES & DEV0 citations48
US7638657B2Dec 29, 2009
Preparation of 3-[5′-(3,4-bis(hydroxymethyl)benzyloxy)-2′-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol
GALDERMA RES & DEV1 citations46
US7319155B2Jan 15, 2008
7,7-disubstituted (5H,9H)-6,8-dioxabenzocycloheptene compounds useful in the synthesis of non-steroidal analogues of vitamin D
GALDERMA RES & DEV0 citations42
SYNTEX PHARMA LTD
4 patentsUS5296609AMar 22, 1994
Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
SYNTEX PHARMA LTD30 citations92
US5428037AJun 27, 1995
Heterocyclic derivatives in the treatment of Ischaemia and related diseases
SYNTEX PHARMA LTD43 citations90
US5378847AJan 3, 1995
Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
SYNTEX PHARMA LTD17 citations81
US5545645AAug 13, 1996
Heterocyclic derivatives in the treatment of ischaemia and related diseases
SYNTEX PHARMA LTD12 citations70
THERAMEX
4 patentsUS6180803B1Jan 30, 2001
19-nor-pregnene derivatives and pharmaceuticals containing such derivatives
THERAMEX20 citations90
US6803380B1Oct 12, 2004
5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
THERAMEX4 citations63
US6737433B1May 18, 2004
1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
THERAMEX3 citations60
US6191292B1Feb 20, 2001
Precursors of the A-ring of vitamin D and method and intermediates for the preparation thereof
THERAMEX2 citations59
BOUIX-PETER CLAIRE
3 patentsUS8871187B2Oct 28, 2014
Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
BOUIX-PETER CLAIRE6 citations80
US9102607B2Aug 11, 2015
Peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne
BOUIX-PETER CLAIRE0 citations49
US8729312B2May 20, 2014
Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne
BOUIX-PETER CLAIRE0 citations49
LAROCHE NAVARRON SA
3 patentsCLARY LAURENCE
2 patentsUS8420632B2Apr 16, 2013
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
CLARY LAURENCE5 citations79
US9266848B2Feb 23, 2016
4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases
CLARY LAURENCE0 citations39